Abstract: The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E2.
Type:
Grant
Filed:
January 13, 2023
Date of Patent:
April 23, 2024
Assignees:
Neuronasal, Inc., Burke Neurological Institute
Inventors:
Rajiv R. Ratan, Saravanan Karuppagounder, Thomas I. Bradshaw
Abstract: This invention relates to methods of administering compounds containing selenium, selenocysteine, or a selenocysteine peptide to treat, for example, conditions associated with selenium deficiency, or ferroptoptic, parthanototic, and endoplasmic reticulum stress, and/or cancer. The methods of treatment may activate or inhibit (via TFAP2C and Sp1 proteins) the adaptive homeostatic response of the selenome. The compounds may contain a targeting sequence that causes them to be delivered to specific organs and/or tissues. The compounds may be administered, for example, orally, intranasally, intravenously, or by a minimally invasive catheter or BrainPath.
Type:
Grant
Filed:
June 30, 2021
Date of Patent:
January 23, 2024
Assignees:
Burke Neurological Institute, University of Vermont and State Agricultural College
Inventors:
Rajiv R. Ratan, Ishraq Alim, Saravanan Karuppagounder, Robert Hondal
Abstract: A method for treating a subject having or likely to develop a neurodegenerative disease, wherein the subject is administered a pharmaceutically effective amount of a compound within the generic structure (1) wherein R1 is either —R or —SR, wherein R is a hydrocarbon group containing 1-20 carbon atoms and optionally containing one or more heteroatoms selected from oxygen, nitrogen, and sulfur; and R2 is selected from the group consisting of —OR?, —OPO32?, and —OC(O)R?, wherein R? is a hydrogen atom or a hydrocarbon group containing 1-6 carbon atoms; and wherein Formula (1) may include pharmaceutically acceptable salts, solvates, and polymorphs thereof, and wherein the subject may be identified as positive, before or during treatment, for at least one marker, including, for example, amyloid plaques, neurofibrillary tangles, decline in brain glucose metabolism, decline in thiamine diphosphate-dependent enzyme activity, and increase in advanced glycation end products.
Type:
Application
Filed:
July 29, 2021
Publication date:
August 17, 2023
Applicants:
CORNELL UNIVERSITY, BURKE NEUROLOGICAL INSTITUTE
Abstract: The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E2.
Type:
Grant
Filed:
December 2, 2019
Date of Patent:
May 30, 2023
Assignees:
NEURONASAL, INC., BURKE NEUROLOGICAL INSTITUTE
Inventors:
Rajiv R. Ratan, Saravanan Karuppagounder, Thomas I. Bradshaw
Abstract: This invention relates to methods of administering compounds containing selenium, selenocysteine, or a selenocysteine peptide to treat, for example, conditions associated with selenium deficiency, or ferroptoptic, parthanototic, and endoplasmic reticulum stress, and/or cancer. The methods of treatment may activate or inhibit (via TFAP2C and Sp1 proteins) the adaptive homeostatic response of the selenome. The compounds may contain a targeting sequence that causes them to be delivered to specific organs and/or tissues. The compounds may be administered, for example, orally, intranasally, intravenously, or by a minimally invasive catheter or BrainPath.
Type:
Grant
Filed:
May 2, 2018
Date of Patent:
August 3, 2021
Assignee:
Burke Neurological Institute
Inventors:
Rajiv R Ratan, Ishraq Alim, I, Saravanan Karuppagounder